Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.

The American journal of surgical pathology - 1 Jul 2010

Thike Aye Aye, Iqbal Jabed, Cheok Poh Yian, Chong Angela Phek Yoon, Tse Gary Man-Kit, Tan Benita, Tan Patrick, Wong Nan Soon, Tan Puay Hoon

Abstract excerpt

We earlier evaluated the relationship of 653 triple negative breast cancers (TNBC) with basal immunophenotypic expression by using antibodies to basal cytokeratins (CK5/6, CK14, CK17, 34betaE12), p63, smooth muscle actin (SMA), epidermal growth factor receptor, and CD117, and found that a triple panel of CK14, 34betaE12 and epidermal growth factor receptor determined 84% of our cases to be basal-like. Women with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ductal, Breast
Share to Carcinoma, Intraductal, Noninfiltrating

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Lymph Nodes

Share to Mastectomy

Share to Muscle, Smooth

Share to Proto-Oncogene Proteins c-kit

Share to Singapore

Source

Identifiers

PMID: 20495445
DOI: 10.1097/PAS.0b013e3181e02f45

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.PMID 20495445Read ↗

Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype.Semantic proximity Read ↗

[Basal-like breast cancers: clinicopathological features and outcome].Semantic proximity Read ↗

c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.Semantic proximity Read ↗

Screening for basal marker expression is necessary for decision of therapeutic strategy for triple-negative breast cancer.Semantic proximity Read ↗

Prognostic relevance of basal cytokeratin expression in operable breast cancer.Semantic proximity Read ↗

Expression of markers of stem cell characteristics, epithelial-mesenchymal transition, basal-like phenotype, proliferation, and androgen receptor in metaplastic breast cancer and their prognostic impact.Semantic proximity Read ↗

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.Semantic proximity Read ↗

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.Semantic proximity Read ↗

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.Semantic proximity Read ↗

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.Semantic proximity Read ↗

Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.Semantic proximity Read ↗

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.